NCT02003391View on ClinicalTrials.gov

Efficacy of Travoprost/Timolol for Uncontrolled Intraocular Pressure

PHASE4CompletedINTERVENTIONAL

Enrollment

157

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Open Angle GlaucomaOcular Hypertension

Interventions

DRUG

Beta-blocker monotherapy

Per participant's current prescribed therapy

DRUG

Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alcon Research

INDUSTRY